Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHeadlam Regulatory News (HEAD)

Share Price Information for Headlam (HEAD)

Share Price is delayed by 15 minutes
Get Live Data
28.40    -1.00 (-3.40%)
Bid:
28.10
Ask:
28.30
Spread: 0.20 (0.712%)
Market Cap: £22.80m
HEAD Live PriceLast checked at - London Stock Exchange

Intraday Headlam Share Chart

Share Buyback Programme

9 Mar 2022 07:02

RNS Number : 1039E
Headlam Group PLC
09 March 2022
 

9 March 2022

Headlam Group plc

('Headlam' or the 'Company')

 

Share Buyback Programme

Headlam (LSE: HEAD), Europe's leading floorcoverings distributor, today announces that it will undertake a share buyback programme of a maximum aggregate consideration of £15.0 million (the 'Share Buyback Programme').

As referenced in January 2022's Pre-Close Trading Update and today's Final Results announcement, the Company's net funds position is comfortably above current capital requirements despite increased levels of investment, and the Company continues to be highly cash generative. As at 31 December 2021, the Company's net funds position (excluding lease liabilities) was £53.7 million. As such, and as set out in today's Final Results, the Company is returning £30.0 million of surplus funds to shareholders. The return is via both a special dividend (£15.0 million) and the Share Buyback Programme (£15.0 million).

 

Details of the special dividend of 17.7 pence per ordinary share of 5 pence each ('Ordinary Share') are given within the Final Results. For the time being an element of capital is being retained on the Company's balance sheet to allow for further investment in the business should the Company wish to accelerate growth projects, to provide flexibility including on the financing of any potential M&A, and also as a prudent precaution against unforeseen events.

The Company has appointed its corporate brokers, Panmure Gordon (UK) Limited ('Panmure Gordon') and Peel Hunt LLP ('Peel Hunt'), to manage the Share Buyback Programme to repurchase Ordinary Shares on the Company's behalf from 10 March 2022.

The Company has entered into an irrevocable commitment with Panmure Gordon and Peel Hunt to operate the Share Buyback Programme through a non-discretionary programme, repurchasing the Ordinary Shares on its behalf, and within certain defined parameters. Panmure Gordon and Peel Hunt will make trading decisions in relation to the buyback of Ordinary Shares independently of the Company within the programme terms.

Share repurchases will take place in open market transactions and may be made from time to time depending on market conditions, share price and trading volume. Under the Share Buyback Programme, the repurchased shares will either be cancelled or held in treasury at the Company's discretion for later reissue or cancellation. Shares held in treasury are not entitled to dividends and have no voting rights at the Company's general meetings.

The Share Buyback Programme is in accordance with Headlam's general authority to purchase a maximum of 8,511,120 Ordinary Shares, granted by its shareholders at the Annual General Meeting held on 21 May 2021, and the purpose of the Share Buyback Programme is to reduce the Company's share capital. The Share Buyback Programme will be conducted within the parameters of the Market Abuse Regulation 596/2014/EU and the Commission Delegated Regulation 2016/1052/EU (each as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018, including where relevant pursuant to the Market Abuse (Amendment)(EU Exit) Regulations 2019) and Chapter 12 of the Listing Rules. The Company confirms that it currently has no other unpublished price sensitive information.

Headlam will make further regulatory announcements in respect of repurchases of Ordinary Shares, including as to whether those shares have been cancelled or are held in treasury.

As of the 8 March 2022, the Company's total issued share capital consisted of 85,639,209 Ordinary Shares, with one voting right per share. The Company held 314,957 Ordinary Shares as treasury shares. Therefore, the total number of voting rights in the Company was 85,324,252.

Headlam Group plc

Tel: 01675 433 000

Chris Payne, Chief Executive

Email:  headlamgroup@headlam.com

Catherine Miles, Director of IR and ESG

Panmure Gordon (UK) Limited (Corporate Broker)

Tel: 020 7886 2500

Erik Anderson / Edward Walsh (Corporate Broking)

Atholl Tweedie / James Sinclair-Ford (Corporate Advisory)

 

 

Peel Hunt LLP (Corporate Broker)

Tel: 020 7418 8900

George Sellar / John Welch / Andrew Clark

Alma PR  (Financial PR)

Tel: 020 3405 0205

Susie Hudson / Rebecca Sanders-Hewett / Lily Soares Smith

Email: headlam@almapr.co.uk

This announcement contains information which, prior to its disclosure, was inside information.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSJPMLTMTMMBFT
Date   Source Headline
24th Jan 20237:00 amRNSTransaction in Own Shares
23rd Jan 20237:00 amRNSTransaction in Own Shares
20th Jan 20237:00 amRNSTransaction in Own Shares
19th Jan 20237:00 amRNSPre-Close Trading Update
18th Jan 20237:00 amRNSTransaction in Own Shares
17th Jan 20237:00 amRNSTransaction in Own Shares
16th Jan 20237:00 amRNSTransaction in Own Shares
13th Jan 20237:00 amRNSTransaction in Own Shares
12th Jan 20237:00 amRNSTransaction in Own Shares
11th Jan 20237:00 amRNSTransaction in Own Shares
10th Jan 20237:00 amRNSTransaction in Own Shares
6th Jan 20237:00 amRNSTransaction in Own Shares
5th Jan 20237:00 amRNSTransaction in Own Shares
4th Jan 20237:00 amRNSTransaction in Own Shares
3rd Jan 202311:35 amRNSTotal Voting Rights
3rd Jan 20237:00 amRNSTransaction in Own Shares
30th Dec 20227:00 amRNSTransaction in Own Shares
29th Dec 20227:00 amRNSTransaction in Own Shares
28th Dec 20227:00 amRNSTransaction in Own Shares
23rd Dec 20227:00 amRNSTransaction in Own Shares
22nd Dec 20227:00 amRNSTransaction in Own Shares
20th Dec 20227:00 amRNSTransaction in Own Shares
19th Dec 202212:00 pmRNSExercise of share options
19th Dec 20227:00 amRNSTransaction in Own Shares
16th Dec 20227:00 amRNSTransaction in Own Shares
15th Dec 20227:00 amRNSTransaction in Own Shares
14th Dec 20227:00 amRNSTransaction in Own Shares
9th Dec 20227:00 amRNSTransaction in Own Shares
8th Dec 202210:29 amRNSHolding(s) in Company
8th Dec 20227:00 amRNSTransaction in Own Shares
7th Dec 20227:00 amRNSTransaction in Own Shares
6th Dec 20227:00 amRNSTransaction in Own Shares
2nd Dec 20227:00 amRNSTransaction in Own Shares
1st Dec 20227:00 amRNSTransaction in Own Shares
30th Nov 20229:44 amRNSTotal Voting Rights
30th Nov 20227:00 amRNSTransaction in Own Shares
29th Nov 20227:00 amRNSTransaction in Own Shares
28th Nov 20227:05 amRNSTransaction in Own Shares
28th Nov 20227:00 amRNSUpdate on Share Buyback Programme
24th Nov 20227:00 amRNSTrading and ESG Update
24th Nov 20227:00 amRNSTransaction in Own Shares
23rd Nov 20227:00 amRNSTransaction in Own Shares
22nd Nov 20227:00 amRNSTransaction in Own Shares
21st Nov 20227:00 amRNSAppointment of Chief Financial Officer
18th Nov 20227:00 amRNSTransaction in Own Shares
17th Nov 20227:00 amRNSTransaction in Own Shares
15th Nov 20227:00 amRNSTransaction in Own Shares
11th Nov 20227:00 amRNSTransaction in Own Shares
10th Nov 20227:00 amRNSTransaction in Own Shares
9th Nov 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.